ICU Medical Inc (ICUI) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide.

Total Revenue Chart for ICU Medical Inc

ICU Medical Inc (ICUI) revenue for FY2025 was USD 2.2B, a -6.4% change from FY2024. ICU Medical Inc's revenue grew from USD 7.5M in 1991 to USD 2.2B in 2025 (29633.7% over 34 years). Earnings per share grew from USD 0.87 in 2000 to USD -3.11 in 2022 (-458.8%). Revenue compound annual growth rate: 5-year CAGR of 11.9%, 10-year CAGR of 20.6%, 20-year CAGR of 14.2%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$4.08B
Implied Share Price
$162.99
Enterprise Value
$5.00B
Revenue (TTM)
$2.16B
EBITDA
$326.12M
Profit Margin
1.39%
Trailing P/E
136.97
Forward P/E
16.95
Price/Book (MRQ)
1.87
Price/Sales (TTM)
1.89
EV/EBITDA
17.59
EV/Revenue
2.31
Dividend Yield
—
Book Value
$86.05
Free Cash Flow (FY2025)
$91.80M
Free Cash Flow Yield
2.25%

Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.